Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to -$514000.0.

  • Marimed's Cash from Investing Activities rose 7580.04% to -$514000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 8930.48%. This contributed to the annual value of -$17.1 million for FY2024, which is 3406.58% up from last year.
  • Latest data reveals that Marimed reported Cash from Investing Activities of -$514000.0 as of Q3 2025, which was up 7580.04% from -$554000.0 recorded in Q2 2025.
  • Marimed's 5-year Cash from Investing Activities high stood at -$115000.0 for Q1 2025, and its period low was -$16.7 million during Q2 2022.
  • For the 5-year period, Marimed's Cash from Investing Activities averaged around -$4.6 million, with its median value being -$4.3 million (2024).
  • In the last 5 years, Marimed's Cash from Investing Activities tumbled by 50138.77% in 2021 and then skyrocketed by 9730.43% in 2025.
  • Marimed's Cash from Investing Activities (Quarter) stood at -$3.2 million in 2021, then rose by 21.93% to -$2.5 million in 2022, then tumbled by 152.61% to -$6.3 million in 2023, then soared by 81.1% to -$1.2 million in 2024, then surged by 57.17% to -$514000.0 in 2025.
  • Its last three reported values are -$514000.0 in Q3 2025, -$554000.0 for Q2 2025, and -$115000.0 during Q1 2025.